Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantMYLAN PHARMACEUTICALS PTE. LTD.
Licence HolderMYLAN PHARMACEUTICALS PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
INTRAVENOUS
Medical Information
L01XA03
oxaliplatin
Manufacturer Information
mylan pharmaceuticals pte. ltd.
Mylan Laboratories Limited [OTL]